Sign in
Taking people in United KingdomNo phase

Retinal Vessel Leakage in People With Small Brain Vessel Disease

Uses eye imaging with fluorescent dye to study leaking vessels in small brain vessel disease.

Key facts

Who runs it
University of Edinburgh
Where
Edinburgh, United KingdomSee the site
Trial code
Registry title
Retinal Vessel Leakage in Cerebral Small Vessel Disease
Status
Recruiting
People taking part
40 people, planned
Started
13 Jan 2025
Expected to end
15 Feb 2029
Type of study
Observational
Treatments tested
  • Fundus fluorescein angiography, with ultrawide field retinal imaging
Record updated
4 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who already take part in the Mild Stroke Study 3 and have had a recent contrast MRI. It checks for leakage from retinal vessels in cerebral small vessel disease.

Age
18 years and older
Sex
All sexes can join.
Earlier treatment
People who had treatment for retinal leakage (retinal laser, intravitreal anti-VEGF) cannot join.

Main reasons for not taking part

  • Any condition known to cause retinal leakage, such as worse than background diabetic retinopathy or wet age-related macular degeneration
  • Previous treatment for retinal leakage (retinal laser, intravitreal anti-VEGF)
  • Pregnancy or renal failure
  • Known allergy to fluorescein, or a history of allergy such as food or drug induced urticaria or bronchial asthma
  • Severe dementia or inability to give informed consent

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Membership in the Mild Stroke Study 3 cohort
  • Contrast enhanced MRI within 12 months
  • Clear optical media in both eyes, as assessed by study investigator
  • Best corrected visual acuity (near vision) ≥N36

Who cannot take part

  • Previous treatment for retinal leakage (retinal laser, intravitreal anti-VEGF)
  • Recent eye surgery
  • Pregnancy, renal failure
  • Severe dementia
  • Known allergy to fluorescein
  • History of allergy such as food or drug induced urticaria or history of bronchial asthma
  • Any other severe or acute medical or psychiatric conditions
  • Any condition known to cause retinal leakage (i.e., worse than background diabetic retinopathy, retinal vein occlusion, active uveitis, wet age-related macular degeneration, malignant hypertension)
  • Shallow anterior chambers as assessed by torch test
  • Inability to give informed consent

Where in United Kingdom

  • NHS LothianEdinburgh, United KingdomContact: Ian MaccormickTaking people

About the trial

What the trial wants to find out

The goal of this observational study is to learn about leakage from retinal vessels in cerebral small vessel disease. The main questions it aims to answer are:

Read full original descriptionShow less

* Does retinal vessel leakage occur in cerebral small vessel disease? * If it does, is the severity of retinal vessel leakage similar to the severity of cerebral small vessel disease generally?

Participants will be tested using fluorescein angiography. This involves an intravenous injection of fluorescent dye, and is a very sensitive way to find leakage from retinal blood vessels.

Participants will have already had brain scans and other examinations and tests to measure the severity of their cerebral small vessel disease. Our new retinal images will complement the information from these previous tests.

Treatments tested

  • Fundus fluorescein angiography, with ultrawide field retinal imaging

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Retinal Vessel Leakage in Cerebral Small Vessel Disease: a Sub-study of the Mild Stroke Study 3
Plain-language title
Retinal Vessel Leakage in People With Small Brain Vessel DiseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
4 March 2026